January 26, 2015 10:18 AM ET


Company Overview of NextWave Pharmaceuticals Incorporated

Company Overview

NextWave Pharmaceuticals Incorporated develops and commercializes pharmaceutical products for the treatment of central nervous system (CNS) and attention deficit hyperactivity disorder (ADHD). Its product pipeline includes NWP06, a methylphenidate extended-release oral suspension for the treatment of ADHD; NWP09, which are methylphenidate extended-release chewable tablets for the treatment of ADHD; and NWP08, which are clonidine extended-release chewable tablets that for the treatment of CNS. The company was formerly known as Children We Care Pharmaceuticals, Inc. The company was incorporated in 2005 and is based in Cupertino, California. As of November 27, 2012, NextWave Pharmaceuticals Inc...

20450 Stevens Creek Boulevard

Suite 150

Cupertino, CA 95014

United States

Founded in 2005





Key Executives for NextWave Pharmaceuticals Incorporated

Vice President of Sales and Marketing
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Boron Biologicals, Inc. United States
Alitair Pharmaceuticals, Inc. United States
GMP Laboratories of America, Inc. United States
The Tapemark Company United States
Cycle Solutions, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NextWave Pharmaceuticals Incorporated, please visit www.nextwavepharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.